The University of Wisconsin Department of Ophthalmology and Visual Sciences is pleased to have many colleagues presenting at this year’s Association for Research in Vision and Ophthalmology annual meeting in Denver, Colorado. View the complete …
All Posts
$2.5 Million Grant Will Help UW Vision Researcher Explore the Virus that Hides in Plain Sight
More than 70% of people worldwide carry Herpes Simplex Virus type 1 (HSV-1) for life. Most know it as the virus behind cold sores—a minor, if annoying, inconvenience. But HSV-1 has a far more serious …
DOVS Hosts Biennial Education Retreat
Faculty and staff in the Department of Ophthalmology and Visual Sciences came together on March 14, 2026, for the biennial Education Retreat—an opportunity to connect, collaborate, and plan for the future of ophthalmic education. The …
Geographic Atrophy on Fundus Autofluorescence and Color Fundus Photographs: Association with Deep Visual Sensitivity Losses.
PubMed ID: 41799798 Author(s): Gee EE, Guymer RH, Blodi BA, Holz FG, Jaffe GJ, Liakopoulos S, Sadda SR, Schmitz-Valckenberg S, Bjelopera E, Brown T, Choong J, Clifton B, Hadoux X, He Y, Heathcote J, Jannaud …
A Steady Hand in the Wet Lab: The Legacy of Dr. Daniel Fary
For more than three decades, ophthalmology residents at the University of Wisconsin—Madison—and their veterinary ophthalmology counterparts—have walked into the cataract surgery wet lab to find the same reassuring presence. A calm confidence and a pair …
Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by at risk patients.
PubMed ID: 41781569 Author(s): Leong A, Wolf RM, Channa R, Wang J, Lehmann H, Abramoff MD, Liu TYA. Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by …
Alumni Spotlight: Jocelyn Rowe, MD ‘11
Ask Jocelyn Rowe, MD ’11, what matters most in medicine, and her answer is simple: the patient in front of you. That perspective, refined during her fellowship training at the University of Wisconsin (UW), continues …
GALLOP
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)
Residents and Faculty Participate in Annual India Global Fieldwork Rotation
For more than half a century, the University of Wisconsin Department of Ophthalmology and Visual Sciences has championed a powerful mission: improving vision and quality of life for people in our community and around the …